遗传 ›› 2019, Vol. 41 ›› Issue (9): 816-826.doi: 10.16288/j.yczz.19-134

• 综述 • 上一篇    下一篇

衰老导致卵巢功能低下研究进展

刘传明1,丁利军1,2,李佳音3,戴建武3(),孙海翔1()   

  1. 1. 南京大学医学院附属鼓楼医院生殖医学中心,南京 210008
    2. 南京大学医学院附属鼓楼医院临床干细胞研究中心,南京 210008
    3. 中国科学院遗传与发育生物学研究所,分子发育生物学国家重点实验室,北京 100190
  • 收稿日期:2019-06-28 修回日期:2019-07-16 出版日期:2019-09-20 发布日期:2019-08-11
  • 通讯作者: 戴建武,孙海翔 E-mail:jwdai@genetics.ac.cn;stevensunz@163.com
  • 作者简介:刘传明,博士,研究方向:生殖医学。E-mail:15950562099@163.com
  • 基金资助:
    国家重点研发计划“生殖健康及重大出生缺陷防控研究”专项编号(2018YFC1004700);中科院战略先导科技专项资助编号(XDA01030501)

Advances in the study of ovarian dysfunction with aging

Chuanming Liu1,Lijun Ding1,2,Jiayin Li3,Jianwu Dai3(),Haixiang Sun1()   

  1. 1. Reproductive Medicine Center, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
    2. Center for Clinical Stem Cell Research, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
    3. State Key Laboratory of Molecular Development Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100190, China
  • Received:2019-06-28 Revised:2019-07-16 Online:2019-09-20 Published:2019-08-11
  • Contact: Dai Jianwu,Sun Haixiang E-mail:jwdai@genetics.ac.cn;stevensunz@163.com
  • Supported by:
    Supported by the National Key Research and Development Program of China No.(2018YFC1004700);The Strategic Priority Research Program of the Chinese Academy of Sciences No(XDA01030501)

摘要:

由于社会角色的转变,女性生育延迟现象明显。女性卵巢功能一般从35岁时开始下降,主要表现为卵泡数量减少和卵母细胞质量下降。目前临床上对于卵巢功能低下的诊断主要依据血清卵泡刺激素(follicle stimulating hormone, FSH)、血清抗苗勒氏管激素(anti-Müllerian hormone, AMH)、窦卵泡计数、年龄、月经和抑制素B等指标。目前研究发现,伴随年龄的增加,女性卵巢内细胞会出现线粒体功能失调、染色质短缩、DNA修复减少、表观遗传学改变和代谢失序。本文在简要介绍卵巢功能低下临床诊断的基础上,对衰老导致卵巢功能低下的相关因素进行了总结,并深入探讨了其发生的分子机制及潜在的干预靶点,以期为有效改善高龄女性的卵巢功能提供思路。

关键词: 卵巢, 衰老, 线粒体, 遗传, 表观遗传

Abstract:

Societal changes regarding the role of women have significant impacts on women’s willingness and the timing of childbearing. Ovarian reserve in woman typically begins to decline at the age of 35, and it is primarily characterized by a reduction in the number of ovarian follicles and a decline in oocyte quality. The clinical diagnosis of ovarian insufficiency relies on multiple variables including changes of follicle stimulating hormone (FSH), serum anti-Müllerian hormone (AMH), inhibin B, antral follicle count, menstruation and age. It is proven that ovarian cells demonstrate dysfunction associated with aging including mitochondrial dysfunction, telomere shortening, impaired DNA repair, epigenetic changes and metabolic/energetic disorders. In this review, we introduce the clinical diagnosis and management of ovarian insufficiency. We mainly discuss the molecular mechanism and potential interventions. We are optimistic that this information and knowledge will inform the important decisions for women and society regarding childbearing.

Key words: ovarian, aging, mitochondrion, heredity, epigenomics